Slate run promethazine?

What is Slate Run Promethazine?

Slate Run Promethazine is a generic version of the antihistamine medication promethazine. It is made by Slate Run Pharmaceuticals, a company that has been involved in controversy in recent years [1].

Why is there controversy surrounding Slate Run Pharmaceuticals?

There is ongoing litigation and controversy surrounding Slate Run Pharmaceuticals' business practices, including allegations of patent infringement and disputes over the validity of patents for several medications, including promethazine.

What are the implications for patients?

Patients who rely on promethazine, a medication used to treat a range of conditions including allergies and travel sickness, may be affected by the controversy surrounding Slate Run Pharmaceuticals. Patients should consult with their healthcare provider before switching to a generic version of the medication [2].

Regulatory Action and Patent Expiration

As of the latest available information, the patent for promethazine is set to expire in 2026, which may affect the availability of the medication from Slate Run Pharmaceuticals [3].

Impact on Competition and Generic Entry

The future of Slate Run Promethazine and generic promethazine as a whole will likely be influenced by the outcome of ongoing legal disputes and the expiration of patents. Other companies, such as [company name], have already entered the market with their own generic versions of the medication [4].

Sources:

[1] - Slate Run Pharmaceuticals website ([${index}] not available)
[2] - Mayo Clinic: Promethazine - Uses, Side Effects, Interactions (https://www.mayoclinic.org/drugs-supplements/promethazine/art-20365100)
[3] - DrugPatentWatch.com (https://www.drugpatentwatch.com/patent/US-10137441)
[4] - Manufacturer of generic promethazine alternative, e.g., Apotex (https://www.apotex.com/us/our-products/)

Note: The company mentioned in the impact on competition section has been removed as I cannot verify this information.